Brief: UK's MHRA Says Sugemalimab Approved To Treat Adult Patients With Non-Small Cell Lung Cancer
30/10/2024 16:48
Oct 30 (Reuters) - MHRA:
* UK'S MHRA: SUGEMALIMAB APPROVED TO TREAT ADULT PATIENTS
WITH
NON-SMALL CELL LUNG CANCER
Further company coverage: 2616.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026